Oaktree Acquisition Corp. III Life Sciences OACC

No annual revenue total was found in OAKTREE ACQUISITION CORP. III LIFE SCIENCES's SEC filings.

Oaktree Acquisition Corp. III Life Sciences (OACC) files with the SEC under industry code 6770, Blank Checks.

Revenue
—
Net income (TTM)
$6.75M
Operating cash flow (TTM)
$-455,689
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
—
Net cash
—
Operating margin
—

Company profile

Industry
Blank Checks (SIC 6770)
Listed as
OACC (Nasdaq), OACCU (Nasdaq), OACCW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Cayman Islands
Headquarters
Los Angeles, CA
SEC filer status
, Emerging growth company
SEC CIK
2029769

Other Blank Checks companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
Operating income
-$1.2M
Net income
$7.3M
Operating cash flow
-$422,079
Total assets
$203.1M
Total liabilities
$8.3M
Stockholders' equity
-$6.8M
Cash and investments
$1.4M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Unregistered share sale, Bylaw or fiscal year change, Shareholder vote results
Oct 26, 2026 Oct 23, 2026
8-K Current report
Regulation FD disclosure
Oct 16, 2026 Oct 16, 2026
8-K Current report
Regulation FD disclosure
Oct 15, 2026 Oct 14, 2026
10-Q Quarterly report Aug 12, 2026 Jun 30, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
10-K Annual report Mar 26, 2026 Dec 31, 2025

Source: SEC EDGAR filings. This is company-reported data, not investment advice.